(4Z,5E)-4,5-di(ethylidene)-1-[2-(4-methylpiperazin-1-yl)acetyl]pyrrolidine-2-carboxylic acid;ethane
C20H37N3O3 — CID 142034250
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4Z,5E)-4,5-di(ethylidene)-1-[2-(4-methylpiperazin-1-yl)acetyl]pyrrolidine-2-carboxylic acid;ethane
(4Z,5E)-4,5-di(ethylidene)-1-[2-(4-methylpiperazin-1-yl)acetyl]pyrrolidine-2-carboxylic acid;ethane (PubChem CID 142034250) has the molecular formula C20H37N3O3 and a molecular weight of 367.53 g/mol. Its IUPAC name is (4Z,5E)-4,5-di(ethylidene)-1-[2-(4-methylpiperazin-1-yl)acetyl]pyrrolidine-2-carboxylic acid;ethane.
Molecular Properties
| Compound Name | (4Z,5E)-4,5-di(ethylidene)-1-[2-(4-methylpiperazin-1-yl)acetyl]pyrrolidine-2-carboxylic acid;ethane |
|---|---|
| PubChem CID | 142034250 |
| Molecular Formula | C20H37N3O3 |
| Molecular Weight | 367.53 g/mol |
| Exact Mass | 367.28 |
| IUPAC Name | (4Z,5E)-4,5-di(ethylidene)-1-[2-(4-methylpiperazin-1-yl)acetyl]pyrrolidine-2-carboxylic acid;ethane |
| SMILES | C/C=C1/CC(C(=O)O)N(C(=O)CN2CCN(C)CC2)/C1=C/C.CC.CC |
| InChI | InChI=1S/C16H25N3O3.2C2H6/c1-4-12-10-14(16(21)22)19(13(12)5-2)15(20)11-18-8-6-17(3)7-9-18;2*1-2/h4-5,14H,6-11H2,1-3H3,(H,21,22);2*1-2H3/b12-4-,13-5+;; |
| InChIKey | FKJSIZMXXYEIQI-RKDUINAVSA-N |
| XLogP | 2.82 |
| TPSA | 64.09 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 367.53 |
| LogP ≤ 5 | 2.82 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 142034250 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.